Logo image of IBG

INNOVATION BEVERAGE GROUP LT (IBG) Stock Fundamental Analysis

NASDAQ:IBG - AU0000226177 - Common Stock

0.5677 USD
-0.01 (-2.54%)
Last: 8/29/2025, 8:00:02 PM
0.5711 USD
+0 (+0.6%)
After Hours: 8/29/2025, 8:00:02 PM
Fundamental Rating

2

Taking everything into account, IBG scores 2 out of 10 in our fundamental rating. IBG was compared to 33 industry peers in the Beverages industry. IBG may be in some trouble as it scores bad on both profitability and health. IBG is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year IBG has reported negative net income.
IBG had a negative operating cash flow in the past year.
IBG Yearly Net Income VS EBIT VS OCF VS FCFIBG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -1M -2M -3M -4M

1.2 Ratios

Looking at the Return On Assets, with a value of -97.18%, IBG is doing worse than 93.94% of the companies in the same industry.
IBG's Return On Equity of -183.88% is on the low side compared to the rest of the industry. IBG is outperformed by 90.91% of its industry peers.
Industry RankSector Rank
ROA -97.18%
ROE -183.88%
ROIC N/A
ROA(3y)-60.99%
ROA(5y)N/A
ROE(3y)-591.24%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IBG Yearly ROA, ROE, ROICIBG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

1.3 Margins

IBG's Gross Margin of 58.09% is amongst the best of the industry. IBG outperforms 81.82% of its industry peers.
IBG's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for IBG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 58.09%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.62%
GM growth 5YN/A
IBG Yearly Profit, Operating, Gross MarginsIBG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 50 -50

More info and screens

3

2. Health

2.1 Basic Checks

IBG does not have a ROIC to compare to the WACC, probably because it is not profitable.
IBG has less shares outstanding than it did 1 year ago.
IBG has a better debt/assets ratio than last year.
IBG Yearly Shares OutstandingIBG Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2M 4M 6M 8M 10M
IBG Yearly Total Debt VS Total AssetsIBG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2M 4M 6M

2.2 Solvency

Based on the Altman-Z score of -2.49, we must say that IBG is in the distress zone and has some risk of bankruptcy.
IBG's Altman-Z score of -2.49 is on the low side compared to the rest of the industry. IBG is outperformed by 81.82% of its industry peers.
IBG has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.16, IBG is in the better half of the industry, outperforming 78.79% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z -2.49
ROIC/WACCN/A
WACC8.32%
IBG Yearly LT Debt VS Equity VS FCFIBG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M -2M

2.3 Liquidity

A Current Ratio of 1.14 indicates that IBG should not have too much problems paying its short term obligations.
With a Current ratio value of 1.14, IBG perfoms like the industry average, outperforming 45.45% of the companies in the same industry.
A Quick Ratio of 0.65 indicates that IBG may have some problems paying its short term obligations.
IBG has a worse Quick ratio (0.65) than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 0.65
IBG Yearly Current Assets VS Current LiabilitesIBG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 1M 2M 3M 4M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for IBG have decreased strongly by -54.16% in the last year.
IBG shows a decrease in Revenue. In the last year, the revenue decreased by -6.88%.
The Revenue has been decreasing by -7.87% on average over the past years.
EPS 1Y (TTM)-54.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%51.23%
Revenue 1Y (TTM)-6.88%
Revenue growth 3Y-7.87%
Revenue growth 5YN/A
Sales Q2Q%-30.52%

3.2 Future

IBG is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.53% yearly.
Based on estimates for the next years, IBG will show a very strong growth in Revenue. The Revenue will grow by 43.78% on average per year.
EPS Next Y47.82%
EPS Next 2Y35.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year55.06%
Revenue Next 2Y43.79%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IBG Yearly Revenue VS EstimatesIBG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2M 4M 6M
IBG Yearly EPS VS EstimatesIBG Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 -0.05 -0.1 -0.15

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IBG. In the last year negative earnings were reported.
Also next year IBG is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IBG Price Earnings VS Forward Price EarningsIBG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IBG Per share dataIBG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6

4.3 Compensation for Growth

IBG's earnings are expected to grow with 35.53% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.53%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

IBG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INNOVATION BEVERAGE GROUP LT

NASDAQ:IBG (8/29/2025, 8:00:02 PM)

After market: 0.5711 +0 (+0.6%)

0.5677

-0.01 (-2.54%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners7.85%
Inst Owner ChangeN/A
Ins Owners17.24%
Ins Owner ChangeN/A
Market Cap5.27M
Analysts80
Price Target4.08 (618.69%)
Short Float %1.7%
Short Ratio0.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.86
P/FCF N/A
P/OCF N/A
P/B 2.01
P/tB 2.31
EV/EBITDA N/A
EPS(TTM)-0.27
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.13
OCFYN/A
SpS0.66
BVpS0.28
TBVpS0.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -97.18%
ROE -183.88%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 58.09%
FCFM N/A
ROA(3y)-60.99%
ROA(5y)N/A
ROE(3y)-591.24%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.62%
GM growth 5YN/A
F-Score5
Asset Turnover1.24
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 4.07%
Cap/Sales 0.16%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 0.65
Altman-Z -2.49
F-Score5
WACC8.32%
ROIC/WACCN/A
Cap/Depr(3y)5.82%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.37%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-54.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%51.23%
EPS Next Y47.82%
EPS Next 2Y35.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.88%
Revenue growth 3Y-7.87%
Revenue growth 5YN/A
Sales Q2Q%-30.52%
Revenue Next Year55.06%
Revenue Next 2Y43.79%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-20.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year56.44%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y0%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y0%
OCF growth 3YN/A
OCF growth 5YN/A